Anti-FGFR2c antibody
Description
Application Data
Description
-
Detects fibroblast growth factor receptor 2c mesenchymal splice variant
Application Data
-
Catalogue number | crb2005090 |
---|---|
Antibody | Anti-FGFR2c antibody |
Antigen Peptide | KLH conjugated synthetic peptide crb1200371e |
Protein ID | UniProtKB - |
Aliases | Fibroblast growth factor receptor 2c, FGFR2c |
Cross-Reactivity | Human |
Target Protein Species | Human |
Host Species | Anti-Rabbit |
Antibody Type | Polyclonal |
Concentration | 1mg/ml |
Validation | 1:1000 (WB), 1:1000 (ELISA) |
Target | FGFR2c |
Storage Stabilisers | This material is supplied in PBS containing 0.01% sodium azide and 1% trehalose. The product should be stored at +4°C for short term storage and -20°C for long term storage. Avoid repeated freeze/ thaw cycles. |
Family | Fibroblast growth factor receptor subfamily |
Disease Area | Signal transduction |
Specificity | Protein |
Storage | This material is supplied in PBS containing 0.01% sodium azide and 1% trehalose. The product should be stored at +4°C for short term storage and -20°C for long term storage. Avoid repeated freeze/ thaw cycles. |
References | Pfaff, M., Xue, K., Li, L., Horowitz, M., Steinbacher, D. and Eswarakumar, J. (2016). FGFR2c-mediated ERK–MAPK activity regulates coronal suture development. Dev Biol, 415(2), 242-250. PMID: 27034231
Ranieri, D., Rosato, B., Nanni, M., Belleudi, F. and Torrisi, M. (2017). Expression of the FGFR2c mesenchymal splicing variant in human keratinocytes inhibits differentiation and promotes invasion. Mol Carcinog, 57(2), 272-283. PMID: 29068468 |
The fibroblast growth factor receptor (FGFR) family consists of four transmembrane receptor tyrosine kinases (FGFR1‐4), which regulate important physiological processes, such as cell proliferation, differentiation, migration and survival throughout the body. FGFR2c is known as the mesenchymal FGFR2 isoform and when aberrantly expressed in epithelial cells it induces epithelial‐mesenchymal transition (EMT) and is involved in cancer progression.
FGFR2 signalling is critical for proper craniofacial development. A gain-of-function mutation in the 2c splice variant is associated with Crouzon syndrome, which is characterized by craniosynostosis, the premature fusion of one or more of the cranial vault sutures, leading to craniofacial maldevelopment. FGFR2c-mediated ERK-MAPK signalling is a key mediator of craniofacial growth and coronal suture development.